TY  - GEN
AU  - Huh,Warner K
AU  - Sill,Michael W
AU  - Darcy,Kathleen M
AU  - Elias,Kevin M
AU  - Hoffman,James S
AU  - Boggess,John F
AU  - Alvarez,Ronald D
AU  - Long,Harry J
AU  - O'Malley,David M
AU  - Birrer,Michael J
TI  - Efficacy and safety of imatinib mesylate (Gleevec) and immunohistochemical expression of c-Kit and PDGFR-beta in a Gynecologic Oncology Group Phase Il Trial in women with recurrent or persistent carcinosarcomas of the uterus
SN  - 1095-6859
PY  - 2010///0419
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Antineoplastic Agents
KW  - adverse effects
KW  - Benzamides
KW  - Carcinosarcoma
KW  - drug therapy
KW  - Disease-Free Survival
KW  - Female
KW  - Humans
KW  - Imatinib Mesylate
KW  - Immunohistochemistry
KW  - Middle Aged
KW  - Neoplasm Recurrence, Local
KW  - Piperazines
KW  - Proto-Oncogene Proteins c-akt
KW  - metabolism
KW  - Proto-Oncogene Proteins c-kit
KW  - biosynthesis
KW  - Pyrimidines
KW  - Receptor, Platelet-Derived Growth Factor beta
KW  - Treatment Outcome
KW  - Uterine Neoplasms
N1  - Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1016/j.ygyno.2010.01.002
ER  -